Interpace Biosciences Inc Umsatz
Was ist das Umsatz von Interpace Biosciences Inc?
Umsatz von Interpace Biosciences Inc ist $26.968M
Was ist die Definition von Umsatz?
Umsatz sind die Einnahmen, die ein Unternehmen aus seiner normalen Geschäftstätigkeit erzielt, normalerweise aus dem Verkauf von Waren und Dienstleistungen an Kunden.
Revenue is also referred to as sales or turnover. Some companies receive revenue from interest, royalties, or other fees. Revenue may refer to business income in general, or it may refer to the amount, in a monetary unit, earned during a period of time, as in "Last year, Company X had revenue of $42 million". Profits or net income generally imply total revenue minus total expenses in a given period.
In accounting, revenue is often referred to as the "top line" due to its position on the income statement at the very top. This is to be contrasted with the "bottom line" which denotes net income.
Umsatz von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Interpace Biosciences Inc
Was macht Interpace Biosciences Inc?
advancing patient care through molecular diagnostic testing. interpace diagnostics develops molecular diagnostic tests. our molecular diagnostic tests provide unparalleled accuracy and clarity to improve outcomes in patients facing a cancer diagnosis. you can be assured that all of the molecular tests we offer are driven by rigorous, validated science. we power the future of molecular diagnostics, delivering cutting-edge and much-needed mutational analysis that helps risk-stratify for thyroid, pancreatic, and other cancers to better inform treatment decisions. the unique molecular diagnostic tests we offer enable healthcare providers to avoid unnecessary surgeries and better assess the risk of cancer progression in their patients.
Unternehmen mit umsatz ähnlich Interpace Biosciences Inc
- Govind Rubber hat Umsatz von ₨26.700M
- Norish Plc hat Umsatz von £26.740M
- Mene hat Umsatz von CAD$26.745M
- Greenrose Acquisition hat Umsatz von $26.784M
- IR Resources hat Umsatz von HKD$26.910M
- Champion Technology hat Umsatz von HKD$26.960M
- Interpace Biosciences Inc hat Umsatz von $26.968M
- Witbe SA hat Umsatz von €27.000M
- Mene hat Umsatz von CAD$27.013M
- GreenBox POS hat Umsatz von $27.037M
- Element 25 hat Umsatz von AUD$27.060M
- Lok'nStore Plc hat Umsatz von £27.100M
- Hennessy Advisors Inc hat Umsatz von $27.126M